Angiotensin II induces TSLP via an AT1 receptor/NF-KappaB pathway, promoting Th17 differentiation

Cellular Physiology and Biochemistry

Volumn 30, Issue 6, 2012, Pages 1383-1397

  Zhao, Hui ^a,b   Li, Ming ^a   Wang, Lei ^a   Su, Yousu ^a   Fang, Hongcheng ^a   Lin, Jing ^a   Mohabeer, Nilesh ^a   Li, Dazhu ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b CHINA THREE GORGES UNIVERSITY   (China)

Author keywords

Angiotensin II; Atherosclerosis; Hypertension; T helper 17 cells; Thymic stromal lymphopoietin

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 17; INTERLEUKIN 23; INTERLEUKIN 6; THYMIC STROMAL LYMPHOPOIETIN; TRANSFORMING GROWTH FACTOR BETA; VALSARTAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; CELL COUNT; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOPLASM; DNA BINDING; GENE EXPRESSION; HYPERTENSION; IMMUNE RESPONSE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; TH17 CELL;

RATTUS;

EID: 84868687273     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000343327     Document Type: Article

References (67)

1. De Goma EM, Knowles JW, Angeli F, Budoff MJ, Rader DJ: The evolution and refinement of traditional risk factors for cardiovascular disease. Cardiol Rev 2012;20:118-129.
2. Wong ND, Nelson JC, Granston T, Bertoni AG, Blumenthal RS, Carr JJ, Guerci A, Jacobs DR Jr, Kronmal R, Liu K, Saad M, Selvin E, Tracy R, Detrano R: Metabolic syndrome, diabetes, and incidence and progression of coronary calcium: the Multiethnic Study of Atherosclerosis study. JACC Cardiovasc Imaging 2012;5:358-366.
3. Tocci G, Rosei EA, Ambrosioni E, Borghi C, Ferri C, Ferrucci A, Mancia G, Morganti A, Pontremoli R, Trimarco B, Zanchetti A, Volpe M: Blood pressure control in Italy: analysis of clinical data from 2005-2011 surveys on hypertension. J Hypertens 2012;30:1065-1074.
4. Lahoute C, Herbin O, Mallat Z, Tedgui A: Adaptive immunity in atherosclerosis. Nat Rev Cardiol 2011;8:348-358.
5. Hansson GK, Hermansson A: The immune system in atherosclerosis. Nat Immunol 2011;12:204-212.
6. Harrison DG, Vinh A, Lob H, Madhur MS: Role of the adaptive immune system in hypertension. Curr Opin Pharmacol 2010;10:203-207.
7. Harrison DG, Guzik TJ, Lob HE, Madhur MS, Marvar PJ, Thabet SR, Vinh A, Weyand CM: Inflammation, immunity, and hypertension. Hypertension 2011;57;132-140.
8. Bi Y, Yang R: Direct and indirect regulatory mechanisms in TH17 cell differentiation and functions. Scand J Immunol 2012;75:543-52.
9. Liu Z, Lu F, Pan H, Zhao Y, Wang S, Sun S, Li J, Hu X, Wang L: Correlation of peripheral Correlation of peripheral Th17 cells and Th17-associatedcytokines to the severity of carotidartery plaque and its clinical implication. Atherosclerosis 2012;221:232-241.
10. Chen S, Crother TR, Arditi M, Chen S, Crother TR, Arditi M: J Innate Immun 2010;2:325-333.
11. Madhur MS, Lob HE, McCann LA, Iwakura Y, Blinder Y, Guzik TJ, Harrison DG: Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction. Hypertension 2010;55:500-507.
12. Usui F, Kimura H, Ohshiro T, Tatsumi K, Kawashima A, Nishiyama A, Iwakura Y, Ishibashi S, Takahashi M: Interleukin-17 deficiency reduced vascular inflammation and development of atherosclerosis in Western diet-induced apoE-deficient mice. Biochem Biophys Res Commun 2012;420:72-77.
13. Smith E, Prasad KM, Butcher M, Dobrian A, Kolls JK, Ley K, Galkina E: Blockade of interleukin-17A results in reduced atherosclerosis in apolipoprotein E-deficient mice. Circulation 2010;121:1746-1755.
14. Dhillon P, Wallace K, Herse F, Scott J, Wallukat G, Heath J, Moseley J, Martin JN Jr, Dechend R, Lamarca B: IL-17 mediated oxidative stress is an important stimulator of AT1-AA and hypertension during pregnancy. Am J Physiol Regul Integr Comp Physiol 2012;303:R353-R358.
15. Banchereau J, Steinman RM: Dendritic cells and the control of immunity. Nature 1998;392:245-252. (Pubitemid 28155090)
16. Laffont S, Powrie F: Immunology: Dendritic-cell genealogy. Nature 2009;462:732-733.
17. Zhang Y, Zhang C: Role of dendritic cells in cardiovascular diseases. World J Cardiol 2010;2:357-364.
18. Ranjit S, Li DZ, Zeng QT, Feng YB, Li YS, Wang X, Chao LS, Tian Y: Differentiation of dendritic cells in monocyte cultures isolated from patients with unstable angina. Int J Cardiol 2004;97:551-555. (Pubitemid 39550709)
19. Li D, Ranjit S, Zeng Q: Functional role of dendritic cells in patients with unstable angina. J Huazhong Univ Sci Technolog Med Sci 2005;25:397-9, 415.
20. Wang L, Li D, Yang K, Hu Y, Zeng Q: Toll-like receptor-4 and mitogen-activated protein kinase signal system are involved in activation of dendritic cells in patients with acute coronary syndrome. Immunology 2008;125:122-130.
21. Yilmaz A, Lochno M, Traeg F, Cicha I, Reiss C, Stumpf C, Raaz D, Anger T, Amann K, Probst T, Ludwig J, Daniel WG, Garlichs CD: Emergence of dendritic cells in rupture-prone regions of vulnerable carotid plaques. Atherosclerosis 2004;176:101-110. (Pubitemid 39078651)
22. Bobryshev YV, Lord R S A: Mapping of vascular dendritic cells in atherosclerotic arteries suggests their involvement in local immune-inflammatory reactions. Cardiovasc Res 1998;37:799-810. (Pubitemid 28231176)
23. Harrison DG, Marvar PJ, Titze JM: Vascular inflammatory cells in hypertension. Front Physiol 2012;3:128.
24. Sata M, Fukuda D: Crucial role of renin-angiotensin system in the pathogenesis of atherosclerosis. J Med Invest 2010;57:12-25.
25. Schmieder RE, Hilgers KF, Schlaich MP, Schmidt BM: Renin-angiotensin system and cardiovascular risk. Lancet 2007;369:1208-1219. (Pubitemid 46527856)
26. Matsuo H, Ichikawa S, Sakamaki T, Ono Z, Kumakura H, Nakamura T, Murata K: Enhanced responses to pressor stimuli by intracerebroventricular infusions of angiotensin II in conscious rats. Jpn Circ J 1986;50:270-277. (Pubitemid 16029017)
27. Saiki Y, Watanabe T, Tan N, Matsuzaki M, Nakamura S: Role of central ANG II receptors in stress-induced cardiovascular and hyperthermic responses in rats. Am J Physiol 1997;272:R26-R33.
28. Guzik TJ, Hoch NE, Brown KA, McCann LA, Rahman A, Dikalov S, Goronzy J, Weyand C, Harrison DG: Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J Exp Med 2007;204:2449-2460. (Pubitemid 47529329)
29. Billet S, Aguilar F, Baudry C, Clauser E: Role of angiotensin II AT1 receptor activation in cardiovascular diseases. Kidney Int 2008;74:1379-1384.
30. Mehta PK, Griendling KK: Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am J Physiol Cell Physiol 2007;292:C82-C97. (Pubitemid 46127306)
31. Ismail H, Mitchell R, McFarlane SI, Makaryus AN: Pleiotropic effects of inhibitors of the RAAS in the diabetic population: above and beyond blood pressure lowering. Curr Diab Rep 2010;10:32-36.
32. Kohno T, Anzai T, Naito K, Sugano Y, Maekawa Y, Takahashi T, Yoshikawa T, Ogawa S: Angiotensinreceptor blockade reduces border zone myocardial monocyte chemoattractant protein-1 expression and macrophage infiltration in post-infarction ventricular remodeling. Circ J 2008;72:1685-1692.
33. Sawada T, Yamada H, Dahlöf B, Matsubara H; KYOTO HEART Study Group: Effects of valsartan on morbidity and mortality in uncontrolled hypertensive patients with high cardiovascular risks: KYOTO HEART Study. Eur Heart J 2009;30:2461-2469.
34. Takai T: TSLP expression: cellular sources, triggers, and regulatory mechanisms. Allergol Int 2012;61:3-17.
35. Soumelis V, Reche PA, Kanzler H, Yuan W, Edward G, Homey B, H, Gilliet M, Ho S, Antonenko S, Lauerma A, Smith K, Gorman D, Zurawski S, Abrams J, Menon S, McClanahan T, De Waal-Malefyt Rd R, Bazan F, Kastelein RA, Liu YJ: Human epithelial cells trigger dendritic cell-mediated allergic inflammation by producing TSLP. Nat Immunol 2002;3:673-680. (Pubitemid 34752477)
36. He R, Geha RS: Thymic stromal lymphopoietin. Ann N Y Acad Sci 2010;1183:13-24.
37. Ziegler SF, Artis D: Sensing the outside world: TSLP regulates barrier immunity. Nat Immunol 2010;11:289-293.
38. Ma P, Bian F, Wang Z, Zheng X, Chotikavanich S, Pflugfelder SC, Li DQ: Human corneal epithelium-derived thymic stromal lymphopoietin links the innate and adaptive immune responses via TLRs and Th2 cytokines. Invest Ophthalmol Vis Sci 2009;50:2702-2709.
39. Tanaka J, Watanabe N, Kido M, Saga K, Akamatsu T, Nishio A, Chiba T: Human TSLP and TLR3 ligands promote differentiation of Th17 cells with a central memory phenotype under Th2-polarizing conditions. Clin Exp Allergy 2009;39:89-100.
40. Spadoni I, Iliev ID, Rossi G, Rescigno M: Dendritic cells produce TSLP that limits the differentiation of Th17 cells, fosters Treg development, and protects against colitis. Mucosal Immuno. 2012;5:184-193.
41. Zhang K, Shan L, Rahman MS, Unruh H, Halayko AJ, Gounni AS: Constitutive and inducible thymic stromal lymphopoietin expression in human airway smooth muscle cells: role in chronic obstructive pulmonary disease. Am J Physiol Lung Cell Mol Physiol 2007;293:L375-L382. (Pubitemid 47205018)
42. Redhu NS, Saleh A, Halayko AJ, Ali AS and Gounni AS: Essential role of NF-κB and AP-1 transcription factors in TNF-a-induced TSLP expression in human airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 2011;300:L479-L485.
43. Doran AC, Meller D, McNamara CA: Role of smooth muscle cells in the initiation and early progression of atherosclerosis. Arterioscler Thromb Vasc Biol 2008;28:812-819. (Pubitemid 351544093)
44. Lee SJ, Kim WJ, Moon SK: TNF-a regulates vascular smooth muscle cell responses in genetic hypertension. Int Immunopharmacol 2009;9:837-843.
45. Ruiz-Ortega M, Lorenzo O, Ruperez M, Esteban V, Suzuki Y, Mezzano S, Plaza JJ, Egido J: Role of the reninangiotensin system in vascular diseases: expanding the field. Hypertension 2001;38:1382-1387. (Pubitemid 34033420)
46. Ruiz-Ortega M, Lorenzo O, Ruperez M, Konig S, Wittig B, Egido J: Angiotensin II activates nuclear transcription factor κB through AT1 and AT2 in vascular smooth muscle cells: molecular mechanisms. Circ Res 2000;86:1266-1272. (Pubitemid 30436668)
47. Schieffer B, Schieffer E, Hilfiker-Kleiner D, Hilfiker A, Kovanen PT, Kaartinen M, Nussberger J, Harringer W, Drexler H: Expression of angiotensin II and interleukin 6 in human coronary atherosclerotic plaques: potential implications for inflammation and plaque instability. Circulation 2000;101:1372-1378. (Pubitemid 30169857)
48. Guo S, Kowalewska J, Wietecha TA, Iyoda M, Wang L, Yi K, Spencer M, Banas M, Alexandrescu S, Hudkins KL, Alpers CE: Renin-angiotensin system blockade is renoprotective in immune complex-mediated glomerulonephritis. J Am Soc Nephrol 2008;19:1168-1176.
49. Jovinge S, Hultgårdh-Nilsson A, Regnström J, Nilsson J: Tumor necrosis factor-alpha activates smooth muscle cell migration in culture and is expressed in the balloon-injured rat aorta. Arterioscler Thromb Vasc Biol 1997;17:490-497. (Pubitemid 27133138)
50. Qiao J, Li A, Jin X: TSLP from RSV-stimulated rat airway epithelial cells activates activates myeloid dendritic cells. Immunol Cell Biol 2011;89:231-238.
51. Wang Q, Gao HB: Involvement of nuclear factor-kappa B on corticosterone-induced rat Leydig cell apoptosis. Asian J Androl 2006;8:693-702. (Pubitemid 44869617)
52. Li XC, Zhuo JL: Nuclear factor-κB as a hormonal intracellular signaling molecule: focus on angiotensin II-induced cardiovascular and renal injury. Curr Opin Nephrol Hypertens 2008;17:37-43. (Pubitemid 350295195)
53. Phillips MI, Kagiyama S: Angiotensin II as a pro-inflammatory mediator. Curr Opin Investig Drugs 2002;3:569-577.
54. Luft FC: Angiotensin, Inflammation, hypertension, and cardiovascular disease. Curr Hypertens Rep 2001;3:61-67.
55. Liu XH, Ji QW, Huang Y, Zeng QT: Th17 response promotes angiotensin II-induced atherosclerosis. Med Hypotheses 2011;76:593-595.
56. Arribas MS, Hermida C, González MC, Wang Y, Hinek A: Enhanced survival of vascular smooth muscle cells accounts for heightened elastin deposition in arteries of neonatal spontaneously hypertensive rats. Exp Physiol 2010;95:550-560.
57. Raines EW, Ferri N: Cytokines affecting endothelial and smooth muscle cells in vascular disease. J Lipid Res 2005;46:1081-1092. (Pubitemid 43109823)
58. Guo R-W, Yang L-X, Wang H, Liu B, Wang L: Angiotensin II induces matrix metalloproteinase-9 expression via a nuclear factor-kappaB-dependent pathway in vascular smooth muscle cells. Regulatory Peptides 2008;147:37-44.
59. Liu J, Yang F, Yang X-P, Jankowski M, Pagano P: NAD (P) H oxidase mediates Angiotensin II-induced vascular macrophage infiltration and medial hypertrophy. Arterioscler Thromb Vasc Biol 2003;23:776-782. (Pubitemid 36569243)
60. Nobuhiko A, Suganuma E, Babaev VR, Fogo A, Swift LL, Linton MF, Fazio S, Ichikawa I, Kon V: Angiotensin II amplifies macrophage-driven atherosclerosis. Arterioscler Thromb Vasc Biol 2004;24:2143-2148. (Pubitemid 39482443)
61. Marvar PJ, Lob H, Vinh A, Zarreen F, Harrison DG: The central nervous system and inflammation in hypertension. Curr Opin Pharmacol 2010;11:1-6.
62. Hartgring SA, Willis CR, Dean CE Jr, Broere F, Van Eden W, Bijlsma JW, Lafeber F P, Van Roon JA: Critical proinflammatory role of thymic stromal lymphopoietin and its receptor in experimental autoimmune arthritis. Arthritis Rheum 2011;63:1878-1887.
63. De Winther M P J, Kanters E, Kraal G, Hofker MH: Nuclear factor κB signaling in atherogenesis. Arterioscler Thromb Vasc Biol 2005;25:904-914.
64. Lee HC, Ziegler SF: Inducible expression of the proallergic cytokine thymic stromal lymphopoietin in airway epithelial cells is controlled by NFκB. Proc Natl Acad Sci USA 2007;104:914-919. (Pubitemid 46154711)
65. Sebastian K, Borowski A, Kuepper M, Friedrich K: Signal transduction around thymic stromal lymphopoietin (TSLP) in atopic asthma. Cell Commun Signal 2008;6:5.
66. Ohba T, Haro H, Ando T, Koyama K, Hatsushika K, Suenaga F, Ohnuma Y, Nakamura Y, Katoh R, Ogawa H, Hamada Y, Nakao A: A potential role of thymic stromal lymphopoietin in the recruitment of macrophages to mouse intervertebral disc cells via monocyte chemotactic protein 1 induction: implications for herniated discs. Arthritis Rheum 2008;58:3510-3519.
67. Moon PD, Kim HM: Thymic stromal lymphopoietin is expressed and produced by caspase-1/NF-κB pathway in mast cells. Cytokine 2011;54:239-243.